Dominik Höchli
Director/Board Member chez MOLECULAR PARTNERS AG
Profil
Dominik Höchli is currently the Chief Executive Officer at Catapult Therapeutics BV and an Independent Director at Molecular Partners AG.
He previously worked as the Vice President & Head-Global Medical Affairs at AbbVie AG.
He holds a doctorate degree from the University of Bern.
Postes actifs de Dominik Höchli
| Sociétés | Poste | Début |
|---|---|---|
| MOLECULAR PARTNERS AG | Director/Board Member | 21/04/2021 |
Catapult Therapeutics BV
 Catapult Therapeutics BV Miscellaneous Commercial ServicesCommercial Services Catapult Therapeutics BV operates as a biopharmaceutical company which develops cancer treatments. It is developing CAP-100, a humanized anti-CCR7 antibody. The company was founded in 2015 and is headquartered in Lelystad, the Netherlands. | Chief Executive Officer | 01/01/2021 |
Anciens postes connus de Dominik Höchli
| Sociétés | Poste | Fin |
|---|---|---|
| AbbVie AG | Corporate Officer/Principal | - |
Formation de Dominik Höchli
| University of Bern | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| MOLECULAR PARTNERS AG | Health Technology |
| Entreprise privées | 2 |
|---|---|
| AbbVie AG | |
Catapult Therapeutics BV
Catapult Therapeutics BV Miscellaneous Commercial ServicesCommercial Services Catapult Therapeutics BV operates as a biopharmaceutical company which develops cancer treatments. It is developing CAP-100, a humanized anti-CCR7 antibody. The company was founded in 2015 and is headquartered in Lelystad, the Netherlands. | Commercial Services |
